These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36964426)

  • 21. Awareness of and interest in oral pre-exposure prophylaxis (PrEP) for HIV prevention and interest in hypothetical forms of PrEP among people who inject drugs in rural West Virginia.
    Schneider KE; White RH; O'Rourke A; Kilkenny ME; Perdue M; Sherman SG; Grieb SM; Allen ST
    AIDS Care; 2021 Jun; 33(6):721-728. PubMed ID: 32951438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical Providers and Harm Reduction Views on Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs.
    Hershow RB; Gonzalez M; Costenbader E; Zule W; Golin C; Brinkley-Rubinstein L
    AIDS Educ Prev; 2019 Aug; 31(4):363-379. PubMed ID: 31361517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study protocol for an efficacy trial of the "PrEP for Health" intervention to increase HIV PrEP use among people who inject drugs.
    Bazzi AR; Bordeu M; Baumgartner K; Sproesser DM; Bositis CM; Krakower DS; Mimiaga MJ; Biello KB
    BMC Public Health; 2023 Mar; 23(1):513. PubMed ID: 36932369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service delivery.
    Shaw G; Schaefer R; Schmidt HA; Madden A; Chang J; Mozalevskis A; Msimanga-Radebe B; Mangadan Konath N; Verster A; Baggaley R; Rodolph M; Macdonald V
    Harm Reduct J; 2023 Feb; 20(1):16. PubMed ID: 36782321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Living at the Confluence of Stigmas: PrEP Awareness and Feasibility Among People Who Inject Drugs in Two Predominantly Rural States.
    Carter G; Meyerson B; Rivers P; Crosby R; Lawrence C; Cope SD; DeBruicker D; Levin S; Meeks W; Thomas C; Turner B; Abert C; Coles H; Allen A; Gonzalez-Fagoaga E; Grivois-Shah R
    AIDS Behav; 2021 Oct; 25(10):3085-3096. PubMed ID: 34003385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington, DC.
    Kuo I; Olsen H; Patrick R; Phillips G; Magnus M; Opoku J; Rawls A; Peterson J; Hamilton F; Kharfen M; Greenberg A
    Drug Alcohol Depend; 2016 Jul; 164():8-13. PubMed ID: 27177804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PrEP Care Continuum Engagement Among Persons Who Inject Drugs: Rural and Urban Differences in Stigma and Social Infrastructure.
    Walters SM; Frank D; Van Ham B; Jaiswal J; Muncan B; Earnshaw V; Schneider J; Friedman SR; Ompad DC
    AIDS Behav; 2022 Apr; 26(4):1308-1320. PubMed ID: 34626265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acceptability of HIV Pre-exposure Prophylaxis (PREP) Among People Who Inject Drugs (PWID) in a Canadian Setting.
    Escudero DJ; Kerr T; Wood E; Nguyen P; Lurie MN; Sued O; Marshall BD
    AIDS Behav; 2015 May; 19(5):752-7. PubMed ID: 25086669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using nominal group technique to identify barriers and facilitators to preventing HIV using combination same-day pre-exposure prophylaxis and medications for opioid use disorder.
    Eger WH; Altice FL; Lee J; Vlahov D; Khati A; Osborne S; Wickersham JA; Bohonnon T; Powell L; Shrestha R
    Harm Reduct J; 2022 Oct; 19(1):120. PubMed ID: 36307817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-World Eligibility for HIV Pre-exposure Prophylaxis Among People Who Inject Drugs.
    Picard J; Jacka B; Høj S; Laverdière É; Cox J; Roy É; Bruneau J
    AIDS Behav; 2020 Aug; 24(8):2400-2408. PubMed ID: 31997057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Providing medication for opioid use disorder and HIV pre-exposure prophylaxis at syringe services programs via telemedicine: a pilot study.
    McKellar MS; Des Marais AC; Chen H; Choi Y; Lilly R; Ayers D; Bennett J; Kestner L; Perry B; Poley S; Corneli A; Meade CS; Sachdeva N
    Harm Reduct J; 2024 Mar; 21(1):69. PubMed ID: 38532395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-Acting Injectable Human Immunodeficiency Virus Pre-Exposure Prophylaxis Preferred Over Other Modalities Among People Who Inject Drugs: Findings from a Qualitative Study in California.
    Bazzi AR; Valasek CJ; Streuli SA; Vera CF; Harvey-Vera A; Philbin MM; Biello KB; Roth AM; Strathdee SA; Pines HA
    AIDS Patient Care STDS; 2022 Jul; 36(7):254-262. PubMed ID: 35727647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A missing perspective: injectable pre-exposure prophylaxis for people who inject drugs.
    Biello KB; Edeza A; Salhaney P; Biancarelli DL; Mimiaga MJ; Drainoni ML; Childs ES; Bazzi AR
    AIDS Care; 2019 Oct; 31(10):1214-1220. PubMed ID: 30822103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV pre-exposure prophylaxis for people who inject drugs: a review of current results and an agenda for future research.
    Escudero DJ; Lurie MN; Kerr T; Howe CJ; Marshall BD
    J Int AIDS Soc; 2014; 17(1):18899. PubMed ID: 24679634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Take services to the people": strategies to optimize uptake of PrEP and harm reduction services among people who inject drugs in Uganda.
    Kamusiime B; Beima-Sofie K; Chhun N; Nalumansi A; Nalukwago GK; Kasiita V; Twesige CC; Kansiime R; Muwonge TR; Kyambadde P; Kadama H; Mudiope P; Glick S; Lambdin B; Mujugira A; Heffron R
    Addict Sci Clin Pract; 2024 Feb; 19(1):13. PubMed ID: 38395940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV Exposure Prophylaxis Delivery in a Low-barrier Substance Use Disorder Bridge Clinic during a Local HIV Outbreak at the Onset of the COVID-19 Pandemic.
    Braun HM; Walter C; Farrell N; Biello KB; Taylor JL
    J Addict Med; 2022 Nov-Dec 01; 16(6):678-683. PubMed ID: 36383918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV providers' likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report.
    Adams LM; Balderson BH
    AIDS Care; 2016 Sep; 28(9):1154-8. PubMed ID: 26915281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. M
    Martel-Laferrière V; Feaster DJ; Metsch LR; Schackman BR; Loignon C; Nosyk B; Tookes H; Behrends CN; Arruda N; Adigun O; Goyer ME; Kolber MA; Mary JF; Rodriguez AE; Yanez IG; Pan Y; Khemiri R; Gooden L; Sako A; Bruneau J
    Trials; 2022 Apr; 23(1):341. PubMed ID: 35461260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city cross-sectional survey.
    Belludi A; McFall AM; Solomon SS; Celentano DD; Mehta SH; Srikrishnan AK; Kumar MS; Solomon S; Lucas GM
    PLoS One; 2021; 16(2):e0247352. PubMed ID: 33630909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs.
    Walters SM; Coston B; Neaigus A; Rivera AV; Starbuck L; Ramirez V; Reilly KH; Braunstein SL
    Int J Drug Policy; 2020 Mar; 77():102671. PubMed ID: 32092665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.